Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fresh Day Meds vs Ilant Health

Fresh Day Meds
Graded #25

Higher grade

vs+27.5
Ilant Health
Graded #408

Lower grade

The verdict

Fresh Day Meds takes it — 84.3/100 to 56.8/100.

Fresh Day Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tight both-molecule spread ($133/$166), verified and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFresh Day Meds +43
88
45
Dose & formulationFresh Day Meds +40
80
40
Clinical oversightFresh Day Meds +1
84
83
Labs & monitoringFresh Day Meds +21
82
61
FulfillmentFresh Day Meds +25
87
62
Contract termsFresh Day Meds +30
85
55
Fresh Day Meds · left barIlant Health · right bar

The numbers

MetricFresh Day MedsIlant Health
WeighScore84.3/10056.8/100
GradeBC
Scorecard rank#25#408
Semaglutide$133/moNot disclosed
Tirzepatide$166/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Fresh Day Meds

Graded #25 · B

Strengths

  • $133 sema / $166 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Monitoring detail not published
  • Newer brand
Ilant Health

Graded #408 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard